AIDS is caused by infection of T4 lymphocytes and macrophages by a human retrovirus, designated as HTLV-III/LAV/HIV virus. We hypothesized that the immune deficiency in AIDS may be in part due to lysis of these critical cells of the immune system by HTLV- III specific, HLA-restricted cytotoxic T lymphocytes (CTL). The definition of CTL responses to HTLV-III virus-infected cells is needed for an improved understanding of the pathogenesis and for optimal approaches at therapy and prevention of AIDS. HTLV-III specific CTL responses will be assessed using as target cells HTLV-III Infected HLA-typed T4+ cell lines. The presence of HTLV-III specific memory CTL in antibody positive subjects will be determined following secondary stimulation in vitro with HTLV-III infected autologous antigen presenting cells. The virus specificity of the MHC-restricted HTLV-III specific CTL will be assessed on target cells infected with various strains of HTLV-III virus, HTLV-I, influenza or herpes simplex virus. It is known that viral specific MHC-restricted CTL recognized epitopes which differ from those recognized by antibodies. We will determine the epitopes recognized by the HTLV-III specific CTL utilizing subvirion peptides to stimulate memory CTL responses and to define the epitopes on target cells recognized by HTLV-III specific CTL. The HLA restriction of HTLV-III specific CTL will be assessed to determine if they are restricted by Class I or Class II antigens and if HLA haplotype preference of peptide or virus induced CTL occurs. Clones of HTLV-III specific human CTL will be developed to analyze the specificity of the virion antigens which induce CTL. The CTL clones will also be used to examine the evolutionary pressure of CTL on HTLV-III virus antigenic variations by subjecting T4+ virus-infected cells to repeated challenge with a CTL clone to determine if CTL resistant infected cells emerge. Clinical investigations will be performed to correlate the clinical stages of HTLV-III infection with the level of HTLV-III specific CTL responses, and to assess the induction of HTLV-III specific memory CTL responses following administration of experimental vaccines. The results of the proposed studies should provide basic insights into the interaction between HTLV-III virion epitopes and HLA-restricted HTLV-III virus specific human CTL, and provided an improved understanding of the pathogenesis and the prevention of AIDS by immunization.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI024750-02
Application #
3137959
Study Section
(SSS)
Project Start
1987-09-30
Project End
1990-08-31
Budget Start
1988-09-01
Budget End
1989-08-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
Schools of Medicine
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Kurane, Ichiro; West, Kim; Tuazon, Carmelita U et al. (2003) Definition of two new epitopes on human immunodeficiency virus type 1 gag protein recognized by human CD8+ cytotoxic T lymphocyte clones. J Clin Virol 27:38-43
Yoo, S; Guarino, L A (1994) Functional dissection of the ie2 gene product of the baculovirus Autographa californica nuclear polyhedrosis virus. Virology 202:164-72
Yoo, S; Guarino, L A (1994) The Autographa californica nuclear polyhedrosis virus ie2 gene encodes a transcriptional regulator. Virology 202:746-53
Demkowicz Jr, W E; Ennis, F A (1993) Vaccinia virus-specific CD8+ cytotoxic T lymphocytes in humans. J Virol 67:1538-44
Kobayashi, K; Takeda, A; Green, S et al. (1993) Direct detection of infectious human immunodeficiency virus type 1 (HIV-1) immune complexes in the sera of HIV-1-infected persons. J Infect Dis 168:729-32
Haubrich, R H; Takeda, A; Koff, W et al. (1992) Studies of antibody-dependent enhancement of human immunodeficiency virus (HIV) type 1 infection mediated by Fc receptors using sera from recipients of a recombinant gp160 experimental HIV-1 vaccine. J Infect Dis 165:545-8
Dai, L C; West, K; Littaua, R et al. (1992) Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes. J Virol 66:3151-4
Littaua, R A; Takeda, A; Cruz, J et al. (1992) Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones. J Virol 66:2274-80
Takeda, A; Robinson, J E; Ho, D D et al. (1992) Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120. J Clin Invest 89:1952-7
Littaua, R A; Oldstone, M B; Takeda, A et al. (1992) A CD4+ cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6. J Virol 66:608-11

Showing the most recent 10 out of 16 publications